top of page
Search
Dec 16, 20204 min read
Immutep Limited - a global leader in development of immunotherapy for cancer & autoimmune diseases
Immutep (ASX: IMM) and (FRA: YP1B) are the global leaders in understanding and development of therapeutics that modulate Lymphocyte...
85 views0 comments
bottom of page